Kabakoff David S - Jun 22, 2023 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
Director
Signature
/s/ Steven P. Cobourn, as attorney-in fact for David S. Kabakoff
Stock symbol
NXTC
Transactions as of
Jun 22, 2023
Transactions value $
$0
Form type
4
Date filed
6/23/2023, 04:31 PM
Previous filing
Jun 24, 2022
Next filing
Jun 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Stock Option (Right to Buy) Award $0 +14.3K $0.00 14.3K Jun 22, 2023 Common Stock 14.3K $1.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders.